NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/25/2022
Back to search
Official data from USPTO
STUART THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
STUART THERAPEUTICS
ST13
US500000088098792Class
5
Filing
88098792
Registration
6739684
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
05/25/2022
Trademark type
Word
Nice classes
5
Filing date
08/30/2018
Registration date
05/24/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/24/2022
Last transaction
05/24/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/01/2019
First use in commerce
07/16/2021
Drawing code
4
Owner type
03
Owner location
Stuart, FL, US
Examiner
MEYERS, MORGAN LAURA
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Stuart Therapeutics, Inc.
Representatives
Jeffrey K. Mills MEDLER FERRO WOODHOUSE & MILLS PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Amino acids for medical or veterinary purposes; Amino acids for medical purposes; Amino acids for veterinary purposes; Anaesthetics; Analgesics; Biological preparations for the treatment of cancer; Biological preparations for the treatment of ocular disorders or diseases; Chemical preparations for pharmaceutical or medical purposesfor ocular disorders or diseases; Collagen for medical purposes; Diagnostic agentspreparations and substances for medical purposes; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Diagnostic reagents for medicinal use; Medicinal preparations for ocular disorders or diseases; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti - infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; Veterinary diagnostic reagents
Publications
History of USPTO decisions and trademark events.
41 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/24/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/22/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/21/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/20/2022
IUAF
USE AMENDMENT FILED
04/15/2022
EISU
TEAS STATEMENT OF USE RECEIVED
04/15/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/23/2021
EX5G
SOU EXTENSION 5 GRANTED
10/22/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/22/2021
EXT5
SOU EXTENSION 5 FILED
10/14/2021
EEXT
SOU TEAS EXTENSION RECEIVED
10/14/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/14/2021
EX4G
SOU EXTENSION 4 GRANTED
04/12/2021
EXT4
SOU EXTENSION 4 FILED
04/12/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/12/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/16/2020
EX3G
SOU EXTENSION 3 GRANTED
10/14/2020
EXT3
SOU EXTENSION 3 FILED
10/14/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/14/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/15/2020
EX2G
SOU EXTENSION 2 GRANTED
04/13/2020
EXT2
SOU EXTENSION 2 FILED
04/13/2020
EEXT
SOU TEAS EXTENSION RECEIVED
04/13/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/17/2019
EX1G
SOU EXTENSION 1 GRANTED
10/15/2019
EXT1
SOU EXTENSION 1 FILED
10/15/2019
EEXT
SOU TEAS EXTENSION RECEIVED
10/15/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/16/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/19/2019
PUBO
PUBLISHED FOR OPPOSITION
02/19/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/30/2019
ALIE
ASSIGNED TO LIE
01/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/17/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
12/17/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/17/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
12/17/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/17/2018
DOCK
ASSIGNED TO EXAMINER
12/13/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/08/2018
NWAP
NEW APPLICATION ENTERED
09/03/2018
Continuous trademark protection
Get notified about every new filing that threatens STUART THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.